To evaluate whether the selective inhibition of SGLT2 is capable of retarding cyst volume progression and delaying renal functional loss, we tested the effect of oral dapagliflozin (DAPA) administration in PCK rats, an orthologous model of ARPKD. This evidence concerns the gene SLC5A2 and cyst.